ASX:AYAHealth Care Equipment & ServicesHealth Care Technology
ARTRYA ORD
$3.135
+$0.035 (+1.13%)
Day Range
$3.000 - $3.175
52 Week Range
$0.560 - $5.240
Volume
198.06K
Avg Volume (10D)
415.48K
Market Cap
$495.59M
Price Chart
Market Statistics
Open$3.050
Previous Close$3.100
Day High$3.175
Day Low$3.000
52 Week High$5.240
52 Week Low$0.560
Valuation
Market Cap495.59M
Shares Outstanding158.08M
Price to Book5.34
Trading Activity
Volume198.06K
Value Traded615.16K
Bid$3.120 × 1,967
Ask$3.150 × 420
Performance
1 Day-2.58%
5 Day-8.21%
13 Week-9.85%
52 Week279.87%
YTD-35.88%
Technical Indicators
RSI (14)42.79
50-Day SMA$3.813
200-Day SMA$2.518
Latest News
Biotechnology
Artrya Secures Second US Commercial Order for Salix SaaS Platform to Manage Coronary Artery Disease
Artrya (ASX: AYA) has signed a commercial agreement with US-based Northeast Georgia Health System for the use of its Salix AI cloud platform for point-of-care assessment and management of coronary artery disease.
1 min read
Biotechnology
Artrya Wins FDA Clearance to Advance Rollout of Salix Coronary Plaque Module
Artrya (ASX: AYA) has received clearance from the US Food and Drug Administration for its Salix Coronary Plaque module. The regulatory milestone enables the company to charge per-scan fees in its largest market, significantly enhancing revenue potential. The approval follows Artrya’s recent US launch and builds on momentum established with its Salix Coronary Anatomy platform. […]
3 min read
